Prudential Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $81.5M | Sell |
130,659
-9,832
| -7% | -$6.69M | 0.09% | 173 |
|
|
2026
Q1 | $109M | Buy |
140,491
+53,333
| +61% | +$40.8M | 0.13% | 137 |
|
|
2025
Q4 | $67.3M | Buy |
87,158
+20,091
| +30% | +$13.6M | 0.08% | 189 |
|
|
2025
Q3 | $37.7M | Buy |
67,067
+5,750
| +9% | +$3.25M | 0.04% | 292 |
|
|
2025
Q2 | $32.2M | Buy |
61,317
+3,768
| +7% | +$2.1M | 0.04% | 309 |
|
|
2025
Q1 | $36.5M | Sell |
57,549
-1,485
| -3% | -$1.02M | 0.05% | 268 |
|
|
2024
Q4 | $42.1M | Sell |
59,034
-10,529
| -15% | -$8.84M | 0.06% | 244 |
|
|
2024
Q3 | $73.1M | Sell |
69,563
-5,322
| -7% | -$5.92M | 0.1% | 173 |
|
|
2024
Q2 | $78.7M | Sell |
74,885
-1,077
| -1% | -$1.04M | 0.12% | 158 |
|
|
2024
Q1 | $73.1M | Sell |
75,962
-1,022
| -1% | -$972K | 0.1% | 184 |
|
|
2023
Q4 | $66.6M | Sell |
76,984
-15,201
| -16% | -$12.5M | 0.1% | 188 |
|
|
2023
Q3 | $75.9M | Sell |
92,185
-1,495
| -2% | -$1.17M | 0.12% | 165 |
|
|
2023
Q2 | $67.3M | Sell |
93,680
-11,501
| -11% | -$8.87M | 0.1% | 189 |
|
|
2023
Q1 | $71.2M | Sell |
105,181
-7,198
| -6% | -$5.43M | 0.11% | 178 |
|
|
2022
Q4 | $81.1M | Sell |
112,379
-6,215
| -5% | -$4.59M | 0.14% | 155 |
|
|
2022
Q3 | $81.7M | Sell |
118,594
-1,806
| -2% | -$1.14M | 0.14% | 146 |
|
|
2022
Q2 | $71.7M | Sell |
120,400
-18,466
| -13% | -$12M | 0.11% | 179 |
|
|
2022
Q1 | $97M | Sell |
138,866
-86,956
| -39% | -$55M | 0.13% | 167 |
|
|
2021
Q4 | $146M | Sell |
225,822
-9,345
| -4% | -$5.75M | 0.18% | 121 |
|
|
2021
Q3 | $142M | Buy |
235,167
+66,742
| +40% | +$41.4M | 0.2% | 107 |
|
|
2021
Q2 | $94.1M | Sell |
168,425
-3,137
| -2% | -$1.59M | 0.13% | 158 |
|
|
2021
Q1 | $81.2M | Buy |
171,562
+81,374
| +90% | +$39.6M | 0.12% | 163 |
|
|
2020
Q4 | $43.6M | Sell |
90,188
-108,921
| -55% | -$58.8M | 0.07% | 248 |
|
|
2020
Q3 | $111M | Buy |
199,109
+18,806
| +10% | +$11.4M | 0.21% | 109 |
|
|
2020
Q2 | $112M | Buy |
180,303
+69,607
| +63% | +$39.5M | 0.21% | 99 |
|
|
2020
Q1 | $54.1M | Sell |
110,696
-27,113
| -20% | -$11.2M | 0.12% | 166 |
|
|
2019
Q4 | $51.7M | Sell |
137,809
-10,135
| -7% | -$3.41M | 0.08% | 261 |
|
|
2019
Q3 | $41M | Sell |
147,944
-79,738
| -35% | -$23.6M | 0.06% | 328 |
|
|
2019
Q2 | $71.3M | Buy |
227,682
+149,119
| +190% | +$49.6M | 0.11% | 185 |
|
|
2019
Q1 | $32.3M | Sell |
78,563
-13,730
| -15% | -$5.65M | 0.05% | 395 |
|
|
2018
Q4 | $34.5M | Buy |
92,293
+8,131
| +10% | +$2.98M | 0.06% | 342 |
|
|
2018
Q3 | $34M | Sell |
84,162
-950
| -1% | -$362K | 0.05% | 408 |
|
|
2018
Q2 | $29.4M | Sell |
85,112
-838
| -1% | -$262K | 0.04% | 468 |
|
|
2018
Q1 | $29.6M | Sell |
85,950
-42,413
| -33% | -$14.8M | 0.05% | 471 |
|
|
2017
Q4 | $48.4M | Buy |
128,363
+3,676
| +3% | +$1.49M | 0.07% | 332 |
|
|
2017
Q3 | $55.8M | Sell |
124,687
-12,301
| -9% | -$5.85M | 0.08% | 272 |
|
|
2017
Q2 | $67.3M | Buy |
136,988
+30,859
| +29% | +$13.5M | 0.1% | 219 |
|
|
2017
Q1 | $41.1M | Buy |
106,129
+1,027
| +1% | +$381K | 0.06% | 336 |
|
|
2016
Q4 | $38.6M | Sell |
105,102
-14,700
| -12% | -$5.59M | 0.06% | 343 |
|
|
2016
Q3 | $48.2M | Sell |
119,802
-2,229
| -2% | -$894K | 0.08% | 271 |
|
|
2016
Q2 | $42.6M | Sell |
122,031
-290
| -0.2% | -$112K | 0.07% | 282 |
|
|
2016
Q1 | $44.1M | Sell |
122,321
-191,540
| -61% | -$78.9M | 0.08% | 263 |
|
|
2015
Q4 | $170M | Buy |
313,861
+83,285
| +36% | +$45.1M | 0.31% | 62 |
|
|
2015
Q3 | $107M | Buy |
230,576
+29,117
| +14% | +$15.6M | 0.21% | 100 |
|
|
2015
Q2 | $103M | Buy |
201,459
+99,615
| +98% | +$48.6M | 0.18% | 117 |
|
|
2015
Q1 | $46M | Sell |
101,844
-8,780
| -8% | -$3.72M | 0.08% | 270 |
|
|
2014
Q4 | $45.4M | Buy |
110,624
+8,200
| +8% | +$3.22M | 0.08% | 263 |
|
|
2014
Q3 | $36.9M | Sell |
102,424
-13,311
| -12% | -$4.46M | 0.07% | 292 |
|
|
2014
Q2 | $32.7M | Buy |
115,735
+5,831
| +5% | +$1.73M | 0.06% | 329 |
|
|
2014
Q1 | $33M | Buy |
109,904
+11,440
| +12% | +$3.52M | 0.06% | 319 |
|
|
2013
Q4 | $27.1M | Sell |
98,464
-1,130
| -1% | -$325K | 0.05% | 364 |
|
|
2013
Q3 | $31.2M | Buy |
99,594
+1,075
| +1% | +$283K | 0.07% | 296 |
|
|
2013
Q2 | $22.2M | Buy |
+98,519
| New | +$22.9M | 0.05% | 374 |
|
Other funds holding REGN
Prudential Financial's REGN Position: Q2 2026 in Review
Prudential Financial reduced its Regeneron Pharmaceuticals (REGN) stake by 7% in Q2 2026, selling an estimated $6.69M and leaving 130,659 shares worth $81.5M. The position accounts for 0.09% of the portfolio, ranked #173.
Prudential Financial first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $170M in Q4 2015. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Prudential Financial held 130,659 shares of Regeneron Pharmaceuticals worth $81.5M as of Q2 2026.
- Prudential Financial sold 9,832 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $6.69M.
- Regeneron Pharmaceuticals made up 0.09% of Prudential Financial's portfolio in Q2 2026, its #173 holding.
- Prudential Financial first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Prudential Financial's Regeneron Pharmaceuticals position peaked at $170M in Q4 2015.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.